Sera Prognostics (SERA)
(Delayed Data from NSDQ)
$2.45 USD
-0.14 (-5.41%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $2.45 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SERA 2.45 -0.14(-5.41%)
Will SERA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SERA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SERA
After Plunging 43.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sera Prognostics (SERA)
Down -30.54% in 4 Weeks, Here's Why Sera Prognostics (SERA) Looks Ripe for a Turnaround
SERA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue Estimates
Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Misses Revenue Estimates
HealthEquity (HQY) Q4 Earnings Miss Estimates
Other News for SERA
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 ...
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
Sera Prognostics: PreTRM Labor Test Should Represent Advance In Risk Assessment
12 Health Care Stocks Moving In Monday's Pre-Market Session